U.S. Logistics Stock News

In recent weeks, Madison Small Cap Fund highlighted Leonardo DRS in its Q1 2026 investor letter after the company delivered better than expected results, helped by its electronic propulsion system on the Columbia-class submarine platform and exposure to the Golden Dome missile defense initiative. At the same time, insider share sales and ongoing benefits from the US Department of War’s move away from larger prime contractors have drawn attention to how Leonardo DRS’s mix of long-term...

DHT Holdings has entered into a new US$250 million seven-year reducing revolving credit facility arranged by Nordea Bank, with interest at SOFR plus 135 basis points, final maturity in June 2033, a 20-year repayment profile, and an additional US$250 million uncommitted accordion for general corporate purposes including refinancing. This expanded facility strengthens DHT’s financial flexibility and extends its debt maturity profile at a time when geopolitical risks around key shipping lanes...

Veralto (VLTO) is back in focus after Metir PLC reported its first PFAS detector sale to the company, linking AI-powered data analysis with Veralto’s global water monitoring projects and core Water Quality segment. See our latest analysis for Veralto. Veralto’s latest share price of US$83.36 comes after a 1-day share price return of 0.87%, although the stock is down 15.37% on a year to date share price basis and 13.92% on a 1 year total shareholder return, suggesting recent momentum has...

Stock move puts Martin Marietta Materials in focus Recent trading interest in Martin Marietta Materials (MLM) has drawn attention to how the stock lines up against its fundamentals, including revenue of US$6,350.0m and net income of US$965.0m. See our latest analysis for Martin Marietta Materials. At a share price of US$577.33, Martin Marietta Materials has seen a 2.08% 1 day share price return and a 3.34% 30 day share price return, although the share price is down 9.00% year to date. The 1...

ADMA Biologics (ADMA) is back in focus after multiple law firms announced securities class action lawsuits alleging channel stuffing, undisclosed related party transactions, and weak internal controls, putting the company’s revenue quality and governance under scrutiny. See our latest analysis for ADMA Biologics. The share price has been under pressure for several months, with a 90 day share price return down 48.17% and a year to date share price return down 54.08%. However, the 5 year total...

Earlier this month, Madison Small Cap Fund disclosed it had initiated a new position in SiteOne Landscape Supply, highlighting the distributor’s scale advantage, high gross margins, and management’s history of operating margin expansion as reasons for its investment. The fund’s emphasis on SiteOne’s role as the leading consolidator in a fragmented landscape supply market, combined with its M&A-led growth approach and intermediary position between suppliers and a diverse customer base,...

Recent performance snapshot First Commonwealth Financial (FCF) has drawn attention after recent share price moves, with the stock up 1.6% over the past day, 4.2% over the past week, and about 10.2% over the past month. See our latest analysis for First Commonwealth Financial. At a share price of $19.91, First Commonwealth Financial has shown firm momentum recently, with a 30 day share price return of 10.24% and a 1 year total shareholder return of 32.59%, pointing to improving sentiment...

Savara (SVRA) is back in focus after announcing that Chief Financial and Administrative Officer Dave Lowrance will step down for health reasons. Chief Operating Officer Robert Lutz will take on the additional CFO role. See our latest analysis for Savara. Savara’s share price return has cooled in recent months, with the stock down 6.7% year to date despite a very large 1 year total shareholder return of 138%, as investors weigh recent leadership changes and the prior authorization to issue...

Albany International (AIN) is back in focus after reporting further progress in its collaboration with Sweden based Cyclezyme AB on enzyme based recycling of polyester and polyamide industrial textiles. See our latest analysis for Albany International. The recent Cyclezyme update arrives after a strong run in Albany International’s share price, with a 30 day share price return of 16.98% and a 90 day share price return of 31.17%. However, the 1 year total shareholder return of 7.65% contrasts...

A sharp rise in call options trading on CF Industries Holdings (CF), along with debate over whether the stock looks undervalued on several metrics, has pulled fresh investor focus to this nitrogen producer. See our latest analysis for CF Industries Holdings. CF’s share price has pulled back recently, with a 30 day share price return of down 12.6% and a 90 day share price return of down 10.5%. However, year to date the share price return is up 36.6% and the 5 year total shareholder return is...

In the past quarter, ManpowerGroup reported Q1 revenues that exceeded analyst expectations and marked a fifth consecutive year-over-year improvement, while unveiling a broad cost, margin, and market-share transformation alongside AI initiatives to enhance client service. Recent ManpowerGroup research, including its Q3 2026 Employment Outlook Survey and Experis’ CIO 2026 Outlook, underscores how employers increasingly value AI literacy and tighter business-IT alignment, reinforcing the...

SpaceX’s record US$75b IPO and US$2t market cap have grabbed headlines, but the ripple effects may matter more for you as an investor. Fresh enthusiasm for mega-IPOs and high-growth stories is colliding with questions about rich valuations and business risk. That mix of optimism and caution is now spilling over into other recently listed large caps that could one day qualify for major indices. This article highlights 3 stocks from our Index Inclusion Beneficiaries screener that are especially...

In early June 2026, DocuSign reported first-quarter revenue of US$830.24 million and net income of US$78.2 million, issued revenue guidance for the July 2026 quarter and the January 2027 fiscal year, announced the availability of its Intelligent Agreement Management app within OpenAI’s ChatGPT and Codex, and appointed former UiPath product chief Graham Sheldon as Chief Product Officer. These updates highlight DocuSign’s push to embed its agreement platform into AI ecosystems while bringing...

Green Brick Partners (GRBK) is back in focus after recent U.S. housing legislation moved forward that restricts institutional investors from buying single family homes, drawing fresh attention to the homebuilder’s position in this shifting policy backdrop. See our latest analysis for Green Brick Partners. Recent news around the revised U.S. housing bill, Green Brick’s role as a core Greenlight Capital holding, and a new chief accounting officer appointment has coincided with a 16.44% 1 month...

RBC coverage and Q1 earnings put Repligen (RGEN) back in focus RBC Capital’s decision to resume coverage of Repligen (RGEN) with a favorable view, following Q1 2026 results that topped revenue and adjusted EPS forecasts, has put the stock back on many investors’ watchlists. See our latest analysis for Repligen. Repligen’s share price has climbed 26.95% over the past 30 days and 13.45% over 90 days, yet remains down 20.54% year to date, while the 1 year total shareholder return is 2.41%,...

In recent days, Veeco Instruments reported the first commercial acceptance and qualification of its LUMINA+ MOCVD system by Ennostar Corporation and secured a follow-on order for its Nanosecond Annealing System from a leading logic customer, both aimed at high-volume advanced semiconductor and optoelectronic production. These back-to-back wins highlight growing adoption of Veeco’s newer process tools across compound semiconductor and advanced logic applications, potentially reinforcing its...

Atlantic Union Bankshares: recent performance snapshot Without a specific headline event driving attention today, Atlantic Union Bankshares (AUB) has still been on many investors’ radars after a period of firm share-price performance and solid reported profitability. The stock closed at US$40.30, with reported revenue of US$1.40b and net income of US$334.19m. Recent returns over the past month and past 3 months have outpaced its single day move. See our latest analysis for Atlantic Union...

Earlier this month, Harley-Davidson outlined plans to bring production of its Revolution Max engine and key models like the Pan America, Sportster S and Nightster back to U.S. facilities as part of its "Back to the Bricks" initiative to rebuild financial performance and dealer relations. This reshoring move arrives as rival Indian Motorcycle’s PR push and questions around Harley-Davidson’s valuation and insider share sales sharpen investor focus on how operational changes could influence...

Cavco Industries (CVCO) has drawn investor attention after its share price moved about 30% over the past month, with the stock last closing at US$592.76 and a market value near US$4.6b. See our latest analysis for Cavco Industries. The recent 30.1% 1 month share price return sits alongside a 15.9% 3 month share price gain and a 49.5% 1 year total shareholder return. Together, these figures point to momentum building as investors reassess Cavco Industries' growth profile and risk. If you are...

BrightSpring Health Services (BTSG) has drawn fresh investor attention after analysts highlighted the stock with strong ratings and Goldman Sachs initiated coverage, alongside the appointment of AI-focused physician Dr. Nigam H. Shah to the Board. See our latest analysis for BrightSpring Health Services. Recent activity reflects that shift in sentiment, with the share price at US$63.23 and strong momentum, including a 90 day share price return of 61.92% and a 1 year total shareholder return...

Evergy’s growth plans meet surging data center demand Evergy (EVRG) has been drawing attention after signing power agreements covering substantial electricity load with technology giants such as Google and Meta, while also outlining a larger multi year capital investment plan to support that demand. See our latest analysis for Evergy. Evergy’s recent customer agreements and higher capital plan have coincided with a 14.74% year to date share price return and a 63.50% five year total...

Why the new orphan drug designation matters for Alkermes (ALKS) The latest catalyst for Alkermes (ALKS) is the US FDA orphan drug designation for alixorexton, its phase 2 oral treatment targeting idiopathic hypersomnia. This status brings specific regulatory incentives and renewed focus on the company’s rare disease pipeline. See our latest analysis for Alkermes. Alkermes’ share price has moved sharply higher in recent months, with a 30 day share price return of 18.14% and a 90 day gain of...

In early June 2026, Advanced Energy Industries filed an omnibus shelf registration covering multiple securities, while also launching its high-efficiency ADH DC-DC converters for 800 V AI data center power architectures and announcing plans to redeem its remaining 2.50% Convertible Senior Notes due 2028. Together, these actions highlight Advanced Energy’s efforts to strengthen its capital flexibility while expanding its role in next-generation AI data center power infrastructure. We’ll now...

Global Partners (GLP) caught investor attention after reporting first quarter 2026 earnings per unit of $1.85, topping analyst expectations, while inflation and volatile energy markets have put fresh focus on its fuel distribution network. See our latest analysis for Global Partners. Despite the strong earnings surprise, the recent share price has slipped, with a 1-day share price return of 5.06% down and a 7-day share price return of 4.03% down, even as the year to date share price return of...